Does homocysteine-lowering treatment improve cardiovascular outcomes in patients with acute coronary syndromes? What we have learned from clinical trials?

Int J Cardiol. 2008 Sep 26;129(2):274-5; author reply 276-7. doi: 10.1016/j.ijcard.2007.06.044. Epub 2007 Aug 8.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Acute Coronary Syndrome / physiopathology
  • Clinical Trials as Topic
  • Evidence-Based Medicine
  • Homocysteine / blood*
  • Homocysteine / drug effects
  • Humans
  • Hyperhomocysteinemia / drug therapy*
  • Prognosis
  • Risk Assessment
  • Treatment Outcome

Substances

  • Homocysteine